Clinical trials recruiting for Inoperable Disease
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Interleukin-2 | 1 |
| Ipilimumab | 1 |
| Nivolumab | 1 |
| ipilimumab+pembrolizumab or ipilimumab+durvalumab, idarubicin, bevacizumab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 1 |
Top cities
Self-screener
Recruiting trials
- Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT
- IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
Related conditions
Trials recruiting for Inoperable Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Inoperable Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.